Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alfred Chung

6PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oral and maxillofacial surgeryGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar

|Dec 27, 2024
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.

Mahmoud R Gaballa, Omar Castaneda Puglianini, Adam Cohen

|Sep 27, 2024
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.

Ashraf Badros, Laahn Foster, Larry D Anderson

|Mar 01, 2024
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.

Kevin R Reyes, Yen-Chun Liu, Chiung-Yu Huang

|Feb 27, 2023
Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study.

Alex Y Ge, Chiung-Yu Huang, Rahul Banerjee

|Aug 30, 2022
Antibody and T-cell responses by ultra-deep T-cell receptor immunosequencing after COVID-19 vaccination in patients with plasma cell dyscrasias.

Alfred Chung, Barbara Banbury, Marissa Vignali

Pageof 1

Frequent Collaborators

2 joint publications

Rahul Banerjee

2 joint publications

Peter Voorhees

1 joint publications

Alex Y Ge

1 joint publications

Thomas G Martin

1 joint publications

Kevin R Reyes

1 joint publications

Chiung-Yu Huang

1 joint publications

Shagun Arora

1 joint publications

Ashraf Badros

1 joint publications

Larry D Anderson

1 joint publications

Chakra P Chaulagain

Frequent Collaborators

2 joint publications

Rahul Banerjee

2 joint publications

Peter Voorhees

1 joint publications

Alex Y Ge

1 joint publications

Thomas G Martin

Top Related Videos

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
09:12

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

745
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

21.3K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

6.4K
See more related videos

Top Related Videos

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
09:12

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

745
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

21.3K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

6.4K
See more related videos